Mehdi Hussain

Biography

Cellugen formerly known as unistem is a biotechnology company dedicated to the multi dimensional applications of umbilical cord derived stem cells. CelluGen group has provided umbilical cord stem cells to over 22,000 transplants since 2001. Prime focus areas for therapeutic applications include neuro degenerative conditions, critical limb ischemia, liver cirrhosis, diabetes, osteoarthritis, optic nerve disorders and COPD among others.  With a strong foundation in complete stem cell services — research and therapy; and collection, processing and cryopreservation of stem cells derived from the umbilical cord — we are currently the only company in India with experience in cord tissue derived stem cell therapies.  OUR MISSION  Our mission is to be the world leader in stem cell research and clinical therapy, thereby, making comprehensive stem cell therapy accessible and cost effective for those in need with a high success rate by following a stringent inclusion and exclusion criteria.  OUR Team CelluGen team have pioneered several new protocols for treatment of Spinal cord injury, Cerebral palsy, Autism, Optic atrophy, Multiple sclerosis, ALS and other neurodegenerative disorders.

Research Interest

treatment of Spinal cord injury, Cerebral palsy, Autism, Optic atrophy, Multiple sclerosis, ALS and other neurodegenerative disorders.